Creon (pancrelipase delayed-release) / AbbVie, Eisai  >>  Phase 2
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Creon (pancrelipase delayed-release) / AbbVie, Eisai
PICNIC, ACTRN12612000299808: Treatment of Pancreatic Insufficiency Using Creon in Patients with Pancreatic Cancer

Terminated
2
60
 
Calvary Mater Newcastle, Calvary Mater Newcastle
Pancreatic carcinoma
 
 
NCT02849704: Fat Malabsorption in Chronic Pancreatitis

Completed
2
48
US
Creon36™, Pancrelipase, CREON
Children's Hospital of Philadelphia, AbbVie, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Phoenix Indian Medical Center
Chronic Pancreatitis
11/17
11/17
NCT03097029: Use of Pancreatic Enzymes in Short Bowel Syndrome

Completed
2
16
US
Pancreatic Enzyme, Creon
Children's Hospital of Philadelphia, AbbVie
Short Bowel Syndrome
02/19
02/19

Download Options